| Laticia Dunn, | |
|
14531 Layhill Rd, Silver Spring, MD 20906-1914 | |
| (240) 338-9791 | |
| Not Available |
| Full Name | Laticia Dunn |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 14531 Layhill Rd, Silver Spring, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073166930 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | T20190680 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Laticia Dunn, 2 Taft Ct, Rockville, MD 20850-1390 Ph: () - | Laticia Dunn, 14531 Layhill Rd, Silver Spring, MD 20906-1914 Ph: (240) 338-9791 |
News Archive
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration granted final approval for the Company's Abbreviated New Drug Application for levofloxacin ophthalmic solution, 0.5% the generic for Vistakon's Quixin ophthalmic solution, which had sales of $2 million for the 12 months ended December 2010 according to IMS sales data.
Research led by a Dignity Health St. Joseph's Hospital and Medical Center physician on ovarian cancer was published in the Feb. 24, 2016 issue of New England Journal of Medicine. The research was directed by Bradley J. Monk, M.D. and researchers at 12 other medical facilities around the nation.
Wellness Formulations, LLC, a leader in anti-glycation research and product development, has launched Dermal Renu® Sunshield daily wear SPF 15 sunscreen. This mineral based sunscreen provides broad-spectrum protection from sun damage caused by UVA/UVB rays, while fighting the signs of aging through a unique combination of anti-glycation agents, antioxidants, moisturizing elements, peptides, and botanical extracts.
Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, today announced that it has received Health Canada approval for MONOVISC™, its single injection viscosupplement approved for the treatment of osteoarthritis of the knee. Anika expects to launch MONOVISC this month through its long-term ORTHOVISC® distribution partner in Canada, Rivex Pharma Inc., the specialty drug distribution division of Aurora, Ontario-based Helix BioPharma Corp. (TSX: HBP). MONOVISC has been broadly available in the European Union since the second quarter of 2008.
› Verified 6 days ago
Aloysius Njoka, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 13836 Castle Blvd Apt 104, Silver Spring, MD 20904 Phone: 240-423-1005 | |
Jeneh Serry, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 11550 Stewart Ln, Apt.504, Silver Spring, MD 20904 Phone: 301-366-3379 | |
Mechebez Fekadu Bereye, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8401 Manchester Rd Apt 501, Silver Spring, MD 20901 Phone: 240-644-8045 | |
Fatima Queen, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1398 Lamberton Dr, Silver Spring, MD 20902 Phone: 301-896-4400 | |
Zainab Namina Kamara, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3227 Bel Pre Rd, Silver Spring, MD 20906 Phone: 301-871-2000 | |
Dannette Moore, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 12103 Sweet Clover Dr, Silver Spring, MD 20904 Phone: 202-251-4285 |